Wachter Kristina, Franke Ulrich F W, Rustenbach Christian J, Baumbach Hardy
Department of Cardiovascular Surgery, Robert-Bosch-Krankenhaus, Stuttgart, Germany.
Thorac Cardiovasc Surg. 2019 Apr;67(3):156-163. doi: 10.1055/s-0038-1627455. Epub 2018 Feb 28.
This review aims to provide an overview on recent data to evaluate minimally invasive (MVAD) and conventional (CVAD) left ventricular assist device (LVAD) implantation. A comprehensive literature search of PubMed, Cochrane Library, and ClinicalTrials.gov was conducted up to April 2017. A total of 183 studies were identified; 13 studies met inclusion criteria. The review revealed a trend toward a lower rate of transfusion, and shorter time for cardiopulmonary bypass, as well as a lower 30-day mortality rate for MVAD. This review indicates that there are possible benefits of minimally invasive LVAD implantation, even though the state of literature is poor.
本综述旨在概述近期数据,以评估微创左心室辅助装置(MVAD)和传统左心室辅助装置(CVAD)植入情况。截至2017年4月,对PubMed、Cochrane图书馆和ClinicalTrials.gov进行了全面的文献检索。共识别出183项研究;13项研究符合纳入标准。该综述显示,MVAD的输血率较低、体外循环时间较短以及30天死亡率较低。本综述表明,尽管文献资料有限,但微创LVAD植入可能具有益处。